BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19223533)

  • 1. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
    Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
    Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
    Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
    J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
    Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
    Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
    Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
    Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.
    Hoshiko S; Kawaguchi M; Fukushima T; Haruyama Y; Yorita K; Tanaka H; Seiki M; Inatsu H; Kitamura K; Kataoka H
    Cancer Res; 2013 Apr; 73(8):2659-70. PubMed ID: 23447577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition.
    Li T; Zeng ZC; Wang L; Qiu SJ; Zhou JW; Zhi XT; Yu HH; Tang ZY
    Cancer Gene Ther; 2011 Sep; 18(9):617-26. PubMed ID: 21637307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Yang AD; Camp ER; Fan F; Shen L; Gray MJ; Liu W; Somcio R; Bauer TW; Wu Y; Hicklin DJ; Ellis LM
    Cancer Res; 2006 Jan; 66(1):46-51. PubMed ID: 16397214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
    Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
    Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.
    Kawaguchi M; Takeda N; Hoshiko S; Yorita K; Baba T; Sawaguchi A; Nezu Y; Yoshikawa T; Fukushima T; Kataoka H
    Am J Pathol; 2011 Oct; 179(4):1815-26. PubMed ID: 21840293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival.
    Kauppinen JM; Kosma VM; Soini Y; Sironen R; Nissinen M; Nykopp TK; Kärjä V; Eskelinen M; Kataja V; Mannermaa A
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2133-42. PubMed ID: 20716618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway.
    Shibata S; Marushima H; Asakura T; Matsuura T; Eda H; Aoki K; Matsudaira H; Ueda K; Ohkawa K
    Int J Oncol; 2009 May; 34(5):1433-48. PubMed ID: 19360357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.